In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin
about
Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation.The effects of enoxaparin on the liver in experimental pneumoperitoneum model.Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models
P2860
In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@ast
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@en
type
label
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@ast
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@en
prefLabel
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@ast
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@en
P2860
P50
P1433
P1476
In-vitro suppression of IL-6 a ...... agulant fraction of enoxaparin
@en
P2093
Niall Stewart
Nuri Gueven
P2860
P304
P356
10.1371/JOURNAL.PONE.0126763
P407
P577
2015-05-11T00:00:00Z